On April 11, 2024, John Chevedden announced that he has filed an exempt solicitation statement with Securities and Exchange Commission, requesting the shareholders of Quest Diagnostics Incorporated to vote for a proposal regarding issue near and long-term science-based greenhouse gas reduction targets aligned with the Paris Agreement?s ambition of limiting global temperature rise to 1.5 °C and summarize plans to achieve them, at the annual meeting of shareholders scheduled to be held on May 16, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
138.2 USD | -0.95% | +1.08% | +0.22% |
Apr. 30 | Baird Adjusts Quest Diagnostics' Price Target to $144 From $138 | MT |
Apr. 29 | US FDA publishes final rule for laboratory developed tests | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.22% | 15.35B | |
-14.25% | 85.35B | |
+14.46% | 81.95B | |
+9.37% | 28.99B | |
-11.40% | 16.98B | |
-0.36% | 16.85B | |
+4.32% | 12.42B | |
-2.34% | 11.88B | |
+32.69% | 12.19B | |
-31.40% | 11.89B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission